Raymond Barlow is the Chief Executive Officer at SynOx Therapeutics, a biopharmaceutical company developing emactuzumab for the treatment of various disorders. Raymond is also the Founder of Ikigai Life Sciences, a consultancy business in the biopharmaceutical industry. With previous experience in companies like Kiadis Pharma, e-therapeutics PLC, and Amgen, Raymond has a strong background in corporate development and business leadership.
Sign up to view 6 direct reports
Get started